Unknown

Dataset Information

0

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies.

ABSTRACT:

Who universal trial numbers (utns)

U1111-1174-4615 and U1111-1174-4698.

Clinicaltrials.gov

NCT04210349 and NCT03430089.

SUBMITTER: Liu X 

PROVIDER: S-EPMC9746500 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies.

Liu Xiaoqiang X   Park Juliana J   Xia Shengli S   Liang Bin B   Yang Shuangmin S   Wang Yanxia Y   Syrkina Olga O   Lavis Nathalie N   Liu Shuzhen S   Zhao Chenyan C   Ding Jian J   Hu Jieqiong J   Samson Sandrine I SI   de Bruijn Iris A IA  

Human vaccines & immunotherapeutics 20221103 6

<h4>Who universal trial numbers (utns)</h4>U1111-1174-4615 and U1111-1174-4698.<h4>Clinicaltrials.gov</h4>NCT04210349 and NCT03430089. ...[more]

Similar Datasets

Unknown A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years.
| S-EPMC3654742 | biostudies-literature
Unknown Cost Effectiveness of Quadrivalent Versus Trivalent Inactivated Influenza Vaccines for the Portuguese Elderly Population.
| S-EPMC9416623 | biostudies-literature
Unknown Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults.
| S-EPMC6605850 | biostudies-literature
Unknown Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons.
| S-EPMC8423477 | biostudies-literature
Unknown Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults.
| S-EPMC3668902 | biostudies-literature
Unknown Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis.
| S-EPMC9225211 | biostudies-literature
Unknown Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years.
| S-EPMC3750613 | biostudies-literature
Unknown Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews.
| S-EPMC10463610 | biostudies-literature
Unknown Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
| S-EPMC8028105 | biostudies-literature
Unknown Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico.
| S-EPMC7227722 | biostudies-literature